How I Approach This With Patients Currently on GLP-1 Medication For patients actively using GLP-1 medications who come to me proactively, before significant skin changes have developed, I focus the conversation on prevention and monitoring rather than correction: supporting skin's structural health through appropriate topical actives, discussing realistic expectations about the pace of weight loss and its relationship to skin's ability to adapt, and establishing a baseline so we can track changes over time rather than only reacting once laxity has become significant
That this legislation potentially threatens their income, too
Nonetheless, these mechanisms have not been consistently replicated in humans, particularly in individuals with severely reduced left ventricular function who may not benefit [72, 73], or may even being harmed [74], from treatment with GLP-1RAs
PLoS ONE 4(4):e5259 AlSaif S, Ponferrada MB, AlKhairy K, AlTawil K, Sallam A, Ahmed I et al (2017) Screening for glucose-6-phosphate dehydrogenase deficiency in neonates: a comparison between cord and peripheral blood samples
Can you switch between treatments
After that, the dose should resume as scheduled the following week
